Literature DB >> 16430399

Breast cancer in limited-resource countries: health care systems and public policy.

Benjamin O Anderson1, Cheng-Har Yip, Scott D Ramsey, Rafael Bengoa, Susan Braun, Margaret Fitch, Martijn Groot, Helene Sancho-Garnier, Vivien D Tsu.   

Abstract

As the largest cancer killer of women around the globe, breast cancer adversely impacts countries at all levels of economic development. Despite major advances in the early detection, diagnosis, and treatment of breast cancer, health care ministries face multitiered challenges to create and support health care programs that can improve breast cancer outcomes. In addition to the financial and organizational problems inherent in any health care system, breast health programs are hindered by a lack of recognition of cancer as a public health priority, trained health care personnel shortages and migration, public and health care provider educational deficits, and social barriers that impede patient entry into early detection and cancer treatment programs. No perfect health care system exists, even in the wealthiest countries. Based on inevitable economic and practical constraints, all health care systems are compelled to make trade-offs among four factors: access to care, scope of service, quality of care, and cost containment. Given these trade-offs, guidelines can define stratified approaches by which economically realistic incremental improvements can be sequentially implemented within the context of resource constraints to improve breast health care. Disease-specific "vertical" programs warrant "horizontal" integration with existing health care systems in limited-resource countries. The Breast Health Global Initiative (BHGI) Health Care Systems and Public Policy Panel defined a stratified framework outlining recommended breast health care interventions for each of four incremental levels of resources (basic, limited, enhanced, and maximal). Reallocation of existing resources and integration of a breast health care program with existing programs and infrastructure can potentially improve outcomes in a cost-sensitive manner. This adaptable framework can be used as a tool by policymakers for program planning and research design to make best use of available resources to improve breast health care in a given limited-resource setting.

Entities:  

Mesh:

Year:  2006        PMID: 16430399     DOI: 10.1111/j.1075-122X.2006.00203.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  48 in total

1.  Sociocultural factors and breast cancer in sub-Saharan Africa: implications for diagnosis and management.

Authors:  Dinah A Tetteh; Sandra L Faulkner
Journal:  Womens Health (Lond)       Date:  2016-01-12

2.  Prioritization of Patients with Abnormal Breast Findings in the Alerta Rosa Navigation Program to Reduce Diagnostic Delays.

Authors:  Jaime Tamez-Salazar; Teresa Mireles-Aguilar; Cynthia de la Garza-Ramos; Marisol Garcia-Garcia; Ana S Ferrigno; Alejandra Platas; Cynthia Villarreal-Garza
Journal:  Oncologist       Date:  2020-08-25

3.  Surgical mammography reporting in a limited resource environment.

Authors:  John P Mouton; Justus Apffelstaedt; Karin Baatjes
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

4.  Breast cancer early detection: A phased approach to implementation.

Authors:  Ophira Ginsburg; Cheng-Har Yip; Ari Brooks; Anna Cabanes; Maira Caleffi; Jorge Antonio Dunstan Yataco; Bishal Gyawali; Valerie McCormack; Myrna McLaughlin de Anderson; Ravi Mehrotra; Alejandro Mohar; Raul Murillo; Lydia E Pace; Electra D Paskett; Anya Romanoff; Anne F Rositch; John R Scheel; Miriam Schneidman; Karla Unger-Saldaña; Verna Vanderpuye; Tsu-Yin Wu; Safina Yuma; Allison Dvaladze; Catherine Duggan; Benjamin O Anderson
Journal:  Cancer       Date:  2020-05-15       Impact factor: 6.860

5.  Breast cancer in young women in a limited-resource environment.

Authors:  Sarinah Basro; Justus P Apffelstaedt
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

6.  Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.

Authors:  Binglan Zhang; Xuelei Ma; Zhimian Li; Xiang Gao; Fengtian Wang; Lei Liu; Guobo Shen; Yaxiong Sang; Minmin Li; Yuli Li; Jingyi Zhao; Yuquan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-06       Impact factor: 4.553

7.  Calponin-h2: a potential serum marker for the early detection of human breast cancer?

Authors:  Manuel Debald; Jian-Ping Jin; Andrea Linke; Klaus-Jürgen Walgenbach; Peter Rauch; Angela Zellmer; Rolf Fimmers; Walther Kuhn; Gunther Hartmann; Gisela Walgenbach-Brünagel
Journal:  Tumour Biol       Date:  2014-08-07

Review 8.  Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative.

Authors:  Benjamin O Anderson; Raimund Jakesz
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

9.  An evaluation of the Train the Trainer International Breast Health and Breast Cancer Education: lessons learned.

Authors:  Karen Dow Meneses; Connie Henke Yarbro
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

10.  Heterozygosity for TGF β1 -509C/T Polymorphism is associated with risk for breast cancer in South Indian population.

Authors:  Cingeetham Vinod; A Jyothy; M Vijay Kumar; R Raghu Raman; Pratibha Nallari; A Venkateshwari
Journal:  Tumour Biol       Date:  2012-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.